胸腔內科

研究成果 1995 2020

篩選
快報
2019
2 引文 (Scopus)

Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly

Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 三月 1 2019, 於 : The European respiratory journal. 53, 3

研究成果: 雜誌貢獻快報

開啟存取
rifapentine
Latent Tuberculosis
Therapeutics
2017
2 引文 (Scopus)

Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?

Chang, C. H., Lee, C. H. & Wang, J. Y., 四月 20 2017, 於 : Journal of Clinical Oncology. 35, 12, p. 1374 1 p.

研究成果: 雜誌貢獻快報

Erlotinib Hydrochloride
Adenocarcinoma of lung
gefitinib
10 引文 (Scopus)
Multidrug-Resistant Tuberculosis
Fluoroquinolones
5 引文 (Scopus)

Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan

Lee, M. R., Ho, C. M., Lee, C. H., Lee, M. C., Chang, L. Y., Yu, K. L., Ko, J. C., Wang, J. Y., Wang, J. T. & Lee, L. N., 八月 1 2017, 於 : The European respiratory journal. 50, 2

研究成果: 雜誌貢獻快報

Contact Tracing
Cost of Illness
Preschool Children
Taiwan
Proportional Hazards Models
2015
2 引文 (Scopus)
AIDS-Related Opportunistic Infections
Pneumocystis carinii
Pneumocystis Pneumonia
Coinfection
Pulmonary Tuberculosis
2009

Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer

Tai, C. J., Hsu, C. H., Wang, F. J., Chau, W. K., Chung, C. L. & Hsieh, C. C., 十一月 2009, 於 : Onkologie. 32, 11, p. 685-686 2 p.

研究成果: 雜誌貢獻快報